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Background: Some studies demonstrated therapeutic angiogenesis attributable to the effects of endothelial
progenitor cells (EPC), others have reported disappointing results. This may be due to the fact that EPC populations
used in these contradictory studies were selected and defined by highly variable and differing experimental protocols.
Indeed, the isolation and reliable characterization of ex vivo differentiated EPC raises considerable problems due to the
fact there is no biomarker currently available to specifically identify EPC exclusively. On the other hand traditional
differentiation of primary immature bone marrow cells towards the endothelial lineage is a time-consuming process of
up to 5 weeks. To circumvent these shortcomings, we herein describe a facile method to isolate and enrich a primary
cell population from rat bone marrow, combining differential attachment methodology with cell sorting technology.
Results: The combination of these techniques enabled us to obtain a pure population of early endothelial precursor
cells that show homogenous upregulation of CD31 and VEGF-R2 and that are positive for CD146. These cells exhibited
typical sprouting on Matrigel™. Additionally, this population displayed endothelial tube formation when resuspended in
Matrigel™ as well as in fibrin glue, demonstrating its functional angiogenic capacity. Moreover, these cells stained
positive for DiI-ac-LDL and FITC-UEA, two markers that are commonly considered to stain differentiating EPCs.
Based upon these observations in this study we describe a novel and time-saving method for obtaining a pure
endothelial precursor cell population as early as 2–3 weeks post isolation that exhibits endothelial abilities in vitro
and which still might have retained its early endothelial lineage properties.
Conclusion: The rapid isolation and the high angiogenic potential of these syngeneic cells might facilitate and
accelerate the pre-vascularization of transplanted tissues and organs also in a human setting in the future.
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The term angiogenesis defines a complex physiological
process where new blood vessels are formed from pre-
existing vessels. In a distinctly different process of vascu-
logenesis, on the other hand, angioblasts differentiate
into endothelial cells in situ, assembling into a vascular
labyrinth. It is generally believed that EPC derive from a
common hematopoietic precursor and contribute to vas-
culogenesis [1]. Indeed, their vasculogenic and angio-
genic potential has been demonstrated in a multitude of
experimental and clinical studies of tissue ischemia,
thereby making them potentially useful for regenerative* Correspondence: oliver.bleiziffer@uk-erlangen.de
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reproduction in any medium, provided the ormedicine applications where generation of new blood
vessels is needed. Bioengineered tissues have become an
essential element in regenerative medicine and tissue en-
gineering applications [2-4]. Once they exceed a critical
size, however, their oxygenation becomes challenging and
can only be maintained by a three-dimensional functional
vascular network. A variety of experimental strategies have
been applied to overcome this problem such as the incorp-
oration of pro-angiogenic growth factors [5,6] or endothe-
lial progenitor cells [7] in these bioengineered constructs.
Addition of EPC constitutes a relatively new approach to
enhance blood vessel formation in bioartificial tissues [8].
Significant research efforts have focused on isolation, defin-
ition, selection and characterization of EPC populations. A
precise definition and delineation of precursor cells with
potent angiogenic properties is still a controversial subject.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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altogether in favor of a precise definition of cellular pheno-
type [9] which again is dependent on the respective algo-
rithm and protocol used for cell selection. Given that
specific cell surface markers to identify endothelial pro-
genitor cells are unknown, it is impossible to separate
the EPC population at an early state of differentiation
by using methodology based on magnetic activated cell
sorting (MACS). Therefore, other approaches such as
the differential attachment method [10-12] have been
used to isolate EPC. However, awaiting outgrowth of a
pure cell population from the pluripotent heterogenous
bone marrow fraction of mononuclear cells (MNC) is
very time consuming.
This study introduces the combination of differential cell
attachment followed by enrichment of the cells via cell
sorting as early as 2 weeks post isolation of the MNC frac-
tion from bone marrow. Our method exploits the ability of
endothelial lineage cells to take up increased amounts of
acetylated low density lipoprotein (ac-LDL) via specialized
scavenger receptors. As a consequence, we were able to en-
rich a population of putative EPC of rat bone marrow
MNC with unusually high purity at an early time point.
We characterized their phenotype using Flow Cytometric
analyses and their angiogenic potency by tube formation
assays in vitro in comparison to a rat endothelial cell line.
Methods
Animals
Male Lewis rats (Charles River Laboratories, Sulzfeld,
Germany) served as donors for the bone marrow. German
regulations for the care and use of laboratory animals
were observed at all time. The animal care committee
of the Unviversity of Erlangen and the government of
Mittelfranken approved all experiments. The animals were
housed in the Franz-Penzoldt-Zentrum in Erlangen and
submitted to a 12-h dark/light cycle with free access to
standard chow (Altromin, Hamburg, Germany) and water.
Cells and culture conditions
The rat endothelium cell line EC52 was used as a posi-
tive control for functional experiments, (A kind gift from
Prof. Dr. U. Rauen, Institute of Physiological Chemistry,
University of Duisburg-Essen). EC52 cells were cultured
in RPMI 1640 medium, supplemented with 20% FBS,
4 mM L-glutamine, dexamethasone (720 ng/ml; Roche
Diagnostics), penicillin (100 U/ml), and streptomycin
(100 mg/ml) in a humidified atmosphere of 5% CO2 in
air (according to provider’s instructions). Cells were split
at ~90% confluency to maintain a constant cell density.
Isolation of mononuclear cells from rat bone marrow
Bones (femur and tibia of hind legs) from 6-week-old male
Lewis rats were repeatedly flushed with PBS containing2% FBS. The washing fluid was centrifuged and the
remaining pellet was resuspended in 10 ml pre-warmed
EGM MV2 medium with FBS, VEGF, R3-IGF-1, rhEGF,
rhbFGF, ascorbic acid and hydrocortisone (PromoCell
GmbH, Heidelberg, Germany). This suspension was filtered
into a single-cell suspension with a 70-μm Cell Strainer
(BD Falcon™, Heidelberg, Germany). Single-cell suspension
was carefully underlaid with 5 ml of Histopaque®-1077
(Sigma-Aldrich Chemie GmbH, Steinheim, Germany). The
mixture was then centrifuged at 2,000 rpm for 20 min
at 20°C without brake to separate the cells into three
layers. The white and cloudy interphase which consists
of the MNC was gently removed and washed with 10 ml
of pre-warmed medium. The pellet was resuspended in
complete medium and seeded in 12-well plates with a
density of 2x106 cells/well. After 24 h the non-adherent
cell population was transferred to gelatin-coated (1%)
plates to remove rapidly adherent hematopoietic cells.
Only the cell population which was non-adherent after
24 h was subjected to additional evaluation.
Flow cytometry (FACS) analyses
Cells were stained for the presence of CD31 (AbD Serotec,
Düsseldorf, Germany) to demonstrate the presence of
endothelial cells, and CD146 (R&D Systems GmbH,
Wiesbaden-Nordenstadt, Germany), a cell adhesion mol-
ecule that is currently used as a marker for endothelial
cell lineage. Additionally, cells were stained for VEGF
receptor-2 (KDR, Abcam, Cambridge, UK). All stainings
were carried out according to manufacturer’s protocols.
Expression of cell surface markers was measured with a
FACS-Calibur running the Cell Quest software (BD Bio-
sciences, San Diego, CA, USA). Raw data were analyzed
with the FlowJo software (Tree Star, Inc., Ashland, OR,
USA). The primary antibody was omitted in the negative
controls. The given percentages in brackets represent the
mean of 4 independent isolations and FACS-analyses
with respect to the upregulation of indicated cell sur-
face markers and the corresponding standard deviation
respectively.
ac-LDL-Uptake and cell sorting
Cells were incubated with 2.5 μg/ml Alexa Fluor®
488-ac-LDL or DiI-ac-LDL (Life Technologies GmbH,
Darmstadt, Germany) for 4 h at 37°C and 5% CO2. Cells
were subsequently washed twice with PBS and directly
analyzed by fluorescence microscopy. Pictures were taken
with an Olympus IX81 inverted microscope running the
cellSens® imaging software (Olympus, Center Valley,
PA, USA). To separate and select the cells that had taken
up the ac-LDL, FACS analysis and sorting was carried
out using a FACS Aria II SORP (BD Biosciences, San
Diego, CA, USA). This machine is part of the Core Unit
Cell Sorting and Immunomonitoring Facility Erlangen.
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seeded again in complete medium (EGM2 MV) for fur-
ther analysis.
FITC-UEA binding
After incubation with DiI-ac-LDL, the selected cell
population was washed twice with PBS and incubated
with 5 μg/ml FITC-UEA (Sigma-Aldrich Chemie GmbH,
Steinheim, Germany) at 37°C and 5% CO2. After an add-
itional washing step with PBS, cells were analyzed by
fluorescence microscopy.
In Vitro capillary tube formation assay using matrigel™
and fibrin
For analysis of capillary tube formation, 75 μl of BD
Matrigel™ (Becton Dickinson, Heidelberg, Germany), an
extracellular mouse sarcoma matrix (Engelbreth-Holm-
Swarm tumor) which is a well-known pro-angiogenic
stimulus in vitro and in vivo, was placed into the wells
of a 96-well plate (Falcon, Heidelberg, Germany) and in-
cubated at 37°C for 60 minutes. Cells were harvested
and suspensions containing 5x104 cells in 150 μl of
EGM MV2 medium were seeded onto the Matrigel™-
coated 96-well plates and incubated for 24 h at 37°C and
5% CO2. The same procedure was used when cells were
resuspended in Matrigel™, only that 1x105 cells were used
under these conditions. After clot formation, 200 μl
EGM2 MV was added on top. Additionally, cells (5x105)
were resuspended in 500 μl fibrin glue (TISSEEL Kit
(Fibrin Sealant), Baxter Healthcare Corporation Westlake
Village, CA 91362 USA), consisting of the two components
Fibrin (1.5 mg/ml, 300 μl) and Thrombin (0.6 IU/ml,
200 μl) and seeded in 48-well plates. After clot formation,
500 μl EGM2 MV was added on top. Capillary tube
formation was observed under an inverted Leica DMIL
microscope and photos were taken using the Leica applica-
tion suite software (Leica Microsystems GmbH, Wetzlar,
Germany) after 24 h of incubation.
Results
Cell morphology and surface marker expression of
isolated rat BM-cells 2 weeks post isolation
Rat MNC isolated from bone marrow by density gradi-
ent and cultured on Gelatin-coated (1%) culture plates
in EGM MV2 exhibited distinct cell morphology typical
of endothelial lineage cells. These cells formed col-
onies that showed pronounced “cobblestone” morphology
(Figure 1a). Analogous observations were made for the rat
liver endothelial cell line EC52 that served as a positive
control for functional experiments in this study. Further-
more, 2 weeks post-isolation, the population demonstrated
to be composed of heterogenous cells in FACS-analyses. A
small fraction of the cells expressed CD31 (Platelet endo-
thelial cell adhesion molecule, PECAM-1) (8.3% ± 2.1)(Figure 1b). CD146, also known as the melanoma cell ad-
hesion molecule (MCAM), was already markedly ex-
pressed on the cells with different intensity (15.7 ± 5.1%)
(Figure 1c). Cells did not express vascular endothelial
growth factor receptor 2 (VEGF-R2/KDR) at this time
point (Figure 1d).
Enrichment and separation of the ac-LDL-positive cell
fraction by cell sorting
A small population of the differentiated MNC derived
from rat bone marrow demonstrated features of endo-
thelial cells, i.e. they incorporated ac-LDL (Figure 2a).
This fraction could be separated from the rest of the cell
population using cell sorting technology. The cells were
enriched and showed a purity of up to 92% (Figure 2b).
Both negative and positive cell fractions were collected
and reseeded on Gelatin-coated culture plates for further
experiments and functional tests.
In Vitro angiogenesis characteristics of sorted
ac-LDL-positive and –negative cell fractions
Positively and negatively sorted cell fractions significantly
differed in terms of morphology. While the positively
sorted fraction showed the “cobblestone” morphology,
typical of endothelial cells and similar to the endothelial
cells serving as positive control, the negatively sorted
fraction exhibited an altogether different growth pattern
(Figure 3, upper row). Furthermore, the capacity to form
tubular networks in 2D as well as in 3D Matrigel™ cul-
tures, an indicator of angiogenic potency, was significantly
different when comparing positively- and negatively-
sorted cells. Only the positive cell fraction demonstrated
network formation on Matrigel™ (Figure 3, 2nd row) and
organization into elongated structures that connected to
each other after suspension within Matrigel™. After sorting
and selection, primary cells appeared to form a higher
degree of connected networks than the endothelial cells
serving as positive control (Figure 3, 3rd row). Negative
control cells were unable to form any networks. Positively-
sorted cells were also able to form connected tubular net-
works in fibrin glue (Figure 3, bottom row).
Cell morphology and surface marker expression of
isolated rat bone marrow-MNC
One week after sorting and reseeding, cells were again
analyzed with regard to their morphology and surface
marker expression as already described above (Figure 1).
Cells still grew in their typical “cobblestone” pattern
and the entire population exhibited a uniform appear-
ance with respect to their expression and expected up-
regulation of CD31 (20.1% ± 6.85%), CD146 (93.25% ±
2.8%) and KDR (26.6% ± 11%) (Figuere 4a-d). Moreover,
cells stained positive for DiI-ac-LDL and FITC-UEA
(Figuere 4e and f). Cells staining positive for both markers
Figure 1 Flow cytometric analyses 2 weeks after isolation and cultivation of rat bone marrow MNC show heterogeneity of the cell
population. (a) Cells were grown in specialized endothelial cell growth medium (EGM2 MV) for 2 weeks after isolation and their morphology
was examined using light microscopy. The scale bar depicts 100 μm. The cells were further analyzed by Flow Cytometry for expression of
endothelial cell-specific surface markers including CD31 (b), CD146 (c) and VEGF-R2 (d). Grey histograms indicate fluorescence signals of negative
controls; white histograms indicate fluorescence signals of specific antigens. Results are representative of 4 separate experiments.
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already reported [13].
Discussion
MNC derived from bone marrow constitute a hete-
rogenous cell population and an easy and straight for-
ward method to isolate and select a uniform population
of cells with potent angiogenic properties, usually re-
ferred to as EPC has not been available to date. Previous
studies have focused on magnetic cell sorting [14] and
MNC adherent culture [15] in order to separate the
EPC. Since there is no unique cell surface marker that
clearly defines the properties of EPC, a population sepa-
rated via magnetic sorting does not necessarily reflect
progenitor cells. EPC separated by adherent culture
comprise many subpopulations and obtaining a uni-
form cell population that expresses a homogenous set of
endothelial surface markers and endothelial propertiesis very time consuming. In the past, early and late
outgrowth EPC have been distinguished and charac-
terized [10], but the isolation methods are fundamentally
based upon their morphology, time of appearance in
culture and lifespan and not upon cellular markers or
properties.
Our study combines for the first time the benefits of
the differential attachment method and the cell sorting
technique, allowing for isolation and enrichment of a pu-
tative EPC population as early as 2 weeks post-isolation.
We observed that MNC from rat bone marrow were
cobblestone-shaped and appeared uniform throughout
the culture 2 weeks post-isolation. Nevertheless, FACS-
analyses of different endothelial cell surface markers
exhibited a very heterogenous population. Hence, mor-
phology and appearance of outgrowing cells from a miscel-
laneous bone marrow fraction should not be considered a
uniform population. This finding precludes the application
Figure 2 The heterogenous cell population can be sorted by the ability of cells of the endothelial lineage to take up ac-LDL 488 via
specialized scavenger receptors. (a) Cells were incubated with 2.5 μg/ml ac-LDL-Alexa Fluor® 488 for 4 h at 37°C and 5% CO2. Cells were
subsequently washed twice with PBS and successful uptake was visualized by fluorescence microscopy (left: brightfield, right: fluorescence). The
scale bar depicts 100 μm. (b) By using cell sorting technology, cells that have taken up the acetylated LDL-AF488 conjugate were successfully
separated from the remaining population with a purity of 92%. Cell distributions are depicted in the plots.
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studies and therapeutic use where a precisely defined and
uniform population is required.
The existing diversity of the population was empha-
sized when ac-LDL-uptake experiments were performed.
In the past, ac-LDL has been frequently used to confirm
endothelial origin of cells based on endothelial-specific
increase of ac-LDL uptake [12,16,17]. We exploited the
scavenger cell pathway of LDL metabolism to label the
cells of the endothelial lineage within the heterogenous
bone marrow population and separated the positive from
the negative fraction using the cell sorting technique as
early as 2 weeks post-isolation, thereby generating a cell
population with a very high purity rate of 92%.
The capillary tube formation assay using extracellular
matrices such as Matrigel™ has been a standard in vitro
assay [8,11,18] to demonstrate the angiogenic potency of
endothelial cells. In our study, the positively sorted cell
fraction demonstrated capacity to form tubular struc-
tures and networks on and within Matrigel™ just as effi-
ciently as the control endothelial cell line EC52, whilethe negatively sorted cells failed to do so. This clearly
emphasizes that it is highly important to separate the
cells of this heterogenous early population before thera-
peutic use. Additionally, the positively sorted cell frac-
tion showed network formation when the cells were
suspended in fibrin glue. Fibrin is a versatile biopolymer
and the prototypical extracellular matrix for tissue regen-
eration and wound healing applications not only in animal
studies but even more so for clinical use where Matrigel™
cannot be employed given that it is of tumor origin. Fibrin,
on the other hand, is biocompatible, biodegradable, easily
processable and, most importantly, approved for clinical
use. It has also been used in a wide variety of experimental
studies towards generation of vascularized bioartificial tis-
sues as an extracellular matrix, cell carrier and growth fac-
tor release system [5,19,20].
Our positively sorted cell population showed up-
regulation and expression of CD31 and KDR with differ-
ent intensity. These molecules are frequently used as
markers to demonstrate the presence of endothelial cells
[11,12,21,22]. All cells stained positively for CD146, a cell
Figure 3 Angiogenic potence in Matrigel and fibrin glue of positively sorted primary cells is equal to an endothelial cell line. Positively
sorted cells, negatively sorted cells and the liver endothelial cell line EC52 (pos. control) were seeded in cell culture flasks and their phenotype
was investigated with light microscopy (top row). 5x104 cells of each population were seeded on Matrigel™ (2nd row) or resuspended in
Matrigel™ (3rd row) and 1x105 cells of each population were suspended in fibrin glue (bottom row) to investigate their performance in tube
formation assays. Microscope pictures were taken 24 h after cell seeding. The scale bar depicts 100 μm.
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for endothelial cell lineage [11,23,24]. All markers exhib-
ited a uniform expression throughout the entire cell
population. Additionally, all the cells incorporated ac-
LDL and bound the lectin UEA-1. As previously reported
[13], cells staining positively for both markers are com-
monly considered to be differentiating EPC. These find-
ings demonstrated homogeneity and uniformity of a cell
population with high angiogenic potential after sorting.
Taken together, our findings demonstrate that MNC
from rat bone marrow show angiogenic characteristics
which are commonly associated with EPC, including
cobblestone-like morphology, lectin-binding, ac-LDL-
uptake, tube formation on and within Matrigel™ or Fibrin
and expression of endothelial cell surface markers. In ac-
cordance with others [9], we do not refer to this enriched
population as EPC, but rather characterize them as early
bone marrow-derived cells of endothelial lineage withhigh angiogenic potential in vitro. As a prospect, in vivo
experiments with this newly isolated cell population have
already been carried out by our group and will soon be
published and discussed elsewhere. Briefly: We used
a syngeneic arteriovenous loop (AV-loop) model in
the rat which is a solitary in vivo system that is used
for the microsurgical vascularization of bioartificial
tissues. It illustrates the development of an emerging
three-dimensional system of blood vessels and is hall-
marked by its high standardization and evaluation prop-
erties. We isolated primary endothelial cells from rat
bone marrow (this study) and tested their angiogenic
potential in the AV-loop model remarkably soon after
cell isolation. Our results demonstrate that this pri-
mary endothelial cell population effectively contrib-
utes to neo-vascularization not only through paracrine
effects but also by their incorporation into the newly built
vessel walls. The rapid isolation and the high angiogenic
Figure 4 A homogenous cell population can be detected in FACS-analyses and ac-LDL-uptake assays one week after sorting. (a) Cells
were grown in EGM2 MV for 1 week after sorting and analyzed with a light microscope for their phenotypic appearance. The cells were further
analyzed by Flow Cytometry for expression of endothelial cell-specific surface markers CD31 (b), CD146 (c) and VEGF-R2 (d). Grey histograms
indicate fluorescence signals of negative controls; white histograms indicate fluorescence signals of specific antigens. Results are representative of
4 separate experiments. Cells were incubated with 2.5 μg/ml ac-LDL-DiI for 4 h at 37°C and 5% CO2. Cells were subsequently washed twice with
PBS and incubated with 5 μg/ml FITC-UEA for 1 h at 37°C and 5% CO2. After an additional washing step with PBS cells were analyzed by fluorescent
microscopy (e: brightfield; f: fluorescence overlay). The scale bar depicts 100 μm.
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erate the pre-vascularization of transplanted tissues and or-
gans in a human setting in the future.
Conclusion
Since there is no unique cell surface marker that clearly
defines the properties of EPC, it is difficult to separate
this fraction at an early time point from a heterogenous
cell population isolated from total bone marrow. Our
method allows for generation of a defined cell popula-
tion as early as 2 to 3 weeks after isolation for experi-
mental use in angiogenesis studies in vitro and in vivo
which is characterized by high purity and retains pro-
genitor cell properties. Based upon our findings we de-
fine this population as an early bone marrow-derived
endothelial cell lineage with high angiogenic potential
in vitro proved by FACS analyses with regard to up-
regulation of specific endothelial cell surface markers,the ability of sprouting and tube formation on and in
Matrigel™/fibrin glue as well as positive staining for
DiI-ac-LDL and FITC-UEA.
Abbreviations
EPC: Endothelial progenitor cells; MACS: Magnetic activated cell sorting;
MNC: Mononuclear cells; ac-LDL: acetylated low density lipoprotein;
FACS: Fluorescence activated cell sorting; VEGF-R2: Vascular endothelial cell
growth factor receptor 2; KDR: Kinase insert domain receptor.
Competing interests
The authors declare that there are no conflicts of interest that would
prejudice the impartiality of this scientific work.
Authors’ contributions
AB, OB and UK designed research. AB and QJ performed research. AB, OB,
QJ, AMB, AA, JPB, and UK analyzed data. AB and OB wrote the manuscript.
All authors read and approved the final manuscript.
Acknowledgments
We would like to thank Prof. Dr. U. Rauen of the Institute of Physiological
Chemistry, University of Duisburg-Essen, for kindly providing the liver
endothelial cell line EC52. We also acknowledge the Core Unit-Cell
Brandl et al. BMC Cell Biology 2014, 15:12 Page 8 of 8
http://www.biomedcentral.com/1471-2121/15/12Sorting and Immunomonitoring, Erlangen University, especially Uwe Appelt and
Markus Mroz. This study was funded by grants from the Else Kröner-Fresenius-
Stiftung (O.B.) and the Xue Hong and Hans Georg Geis-Stiftung (R.E.H).
Received: 25 April 2013 Accepted: 21 March 2014
Published: 26 March 2014References
1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T,
Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor
endothelial cells for angiogenesis. Science 1997, 275:964–967.
2. Horch RE, Kneser U, Polykandriotis E, Schmidt VJ, Sun J, Arkudas A: Tissue
engineering and regenerative medicine -where do we stand? J Cell Mol
Med 2012, 16:1157–1165.
3. Polykandriotis E, Schmidt VJ, Kneser U, Jianming S, Boccaccini AR, Horch RE:
Bioreactors in regenerative medicine–from a technical device to a
reconstructive alternative? Handchir Mikrochir Plast Chir 2012, 44:198–203.
4. Rath SN, Strobel LA, Arkudas A, Beier JP, Maier AK, Greil P, Horch RE, Kneser U:
Osteoinduction and survival of osteoblasts and bone-marrow stromal cells
in 3D biphasic calcium phosphate scaffolds under static and dynamic culture
conditions. J Cell Mol Med 2012, 16:2350–2361.
5. Arkudas A, Tjiawi J, Bleiziffer O, Grabinger L, Polykandriotis E, Beier JP, Sturzl M,
Horch RE, Kneser U: Fibrin gel-immobilized VEGF and bFGF efficiently
stimulate angiogenesis in the AV loop model. Mol Med 2007, 13:480–487.
6. Zhang Y, Schedle A, Matejka M, Rausch-Fan X, Andrukhov O: The proliferation
and differentiation of osteoblasts in co-culture with human umbilical vein
endothelial cells: an improved analysis using fluorescence-activated cell
sorting. Cell Mol Biol Lett 2010, 15:517–529.
7. Bleiziffer O, Hammon M, Naschberger E, Lipnik K, Arkudas A, Rath S,
Pryymachuk G, Beier JP, Sturzl M, Horch RE, Kneser U: Endothelial
progenitor cells are integrated in newly formed capillaries and alter
adjacent fibrovascular tissue after subcutaneous implantation in a fibrin
matrix. J Cell Mol Med 2011, 15:2452–2461.
8. Amini AR, Laurencin CT, Nukavarapu SP: Differential analysis of
peripheral blood- and bone marrow-derived endothelial progenitor
cells for enhanced vascularization in bone tissue engineering.
J Orthop Res 2012, 30:1507–1515.
9. Deb A, Patterson C: Hard luck stories: the reality of endothelial progenitor
cells continues to fall short of the promise. Circulation 2010, 121:850–852.
10. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, Park
YB: Characterization of two types of endothelial progenitor cells and
their different contributions to neovasculogenesis. Arterioscler Thromb
Vasc Biol 2004, 24:288–293.
11. Kahler CM, Wechselberger J, Hilbe W, Gschwendtner A, Colleselli D,
Niederegger H, Boneberg EM, Spizzo G, Wendel A, Gunsilius E, Patsch JR,
Hamacher J, Patsch JR, Hamacher J: Peripheral infusion of rat bone
marrow derived endothelial progenitor cells leads to homing in acute
lung injury. Respir Res 2007, 8:50.
12. Yang N, Li D, Jiao P, Chen B, Yao S, Sang H, Yang M, Han J, Zhang Y, Qin S:
The characteristics of endothelial progenitor cells derived from
mononuclear cells of rat bone marrow in different culture conditions.
Cytotechnology 2011, 63:217–226.
13. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K,
Ferkowicz MJ, Gilley D, Yoder MC: Identification of a novel hierarchy of
endothelial progenitor cells using human peripheral and umbilical cord
blood. Blood 2004, 104:2752–2760.
14. Casamassimi A, Balestrieri ML, Fiorito C, Schiano C, Maione C, Rossiello R,
Grimaldi V, Del Giudice V, Balestrieri C, Farzati B, Sica V, Napoli C, Sica V,
Napoli C: Comparison between total endothelial progenitor cell isolation
versus enriched Cd133+ culture. J Biochem 2007, 141:503–511.
15. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T:
Circulating endothelial progenitor cells, vascular function, and cardiovascular
risk. N Engl J Med 2003, 348:593–600.
16. Fedorovich NE, Haverslag RT, Dhert WJ, Alblas J: The role of endothelial
progenitor cells in prevascularized bone tissue engineering:
development of heterogeneous constructs. Tissue Eng Part A 2010,
16:2355–2367.
17. Voyta JC, Via DP, Butterfield CE, Zetter BR: Identification and isolation of
endothelial cells based on their increased uptake of acetylated-low
density lipoprotein. J Cell Biol 1984, 99:2034–2040.18. Arnaoutova I, George J, Kleinman HK, Benton G: The endothelial cell tube
formation assay on basement membrane turns 20: state of the science
and the art. Angiogenesis 2009, 12:267–274.
19. Ahmed TA, Dare EV, Hincke M: Fibrin: a versatile scaffold for tissue
engineering applications. Tissue Eng Part B Rev 2008, 14:199–215.
20. Polykandriotis E, Tjiawi J, Euler S, Arkudas A, Hess A, Brune K, Greil P,
Lametschwandtner A, Horch RE, Kneser U: The venous graft as an effector
of early angiogenesis in a fibrin matrix. Microvasc Res 2008, 75:25–33.
21. Mutunga M, Fulton B, Bullock R, Batchelor A, Gascoigne A, Gillespie JI,
Baudouin SV: Circulating endothelial cells in patients with septic shock.
Am J Respir Crit Care Med 2001, 163:195–200.
22. Woywodt A, Schroeder M, Mengel M, Schwarz A, Gwinner W, Haller H,
Haubitz M: Circulating endothelial cells are a novel marker of
cyclosporine-induced endothelial damage. Hypertension 2003, 41:720–723.
23. Smadja DM, Mauge L, Gaussem P, d’Audigier C, Israel-Biet D, Celermajer DS,
Bonnet D, Levy M: Treprostinil increases the number and angiogenic
potential of endothelial progenitor cells in children with pulmonary
hypertension. Angiogenesis 2011, 14:17–27.
24. Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP: Circulating
activated endothelial cells in sickle cell anemia. N Engl J Med 1997,
337:1584–1590.
doi:10.1186/1471-2121-15-12
Cite this article as: Brandl et al.: A novel early precursor cell population
from rat bone marrow promotes angiogenesis in vitro. BMC Cell Biology
2014 15:12.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
